SCHEMBL26570867

SCHEMBL26570867

CC(C)(C)OC(=O)CNC(=O)c1ccc(-c2ccccc2)c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 4/20 0.63
GABRA5 P31644 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 1/20 0.43
CTSL P07711 1/20 0.42
PTPN13 Q12923 1/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
MAPK1 P28482 1/20 0.42
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
PTGS1 P23219 3/20 0.41
MEN1 O00255 2/20 0.41
PTGS2 P35354 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31725067 0.86 PTPRC (0.65) PTPRCGABRA5ALDH1A1CTSLPTPN13
SCHEMBL26570869 0.83 PTPRC (0.59) PTPRCSMN1; SMN2ALDH1A1LMNACYP2C19
SCHEMBL30759189 0.79 PTPRC (0.55) PTPRCSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL27113111 0.79 PTPRC (0.55) PTPRCSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL6084716 0.78 PTPRC (0.62) PTPRCSMN1; SMN2LMNARAB9A
SCHEMBL6260964 0.78 PTPRC (1.00) PTPRCSMN1; SMN2ALDH1A1LMNACTSL
SCHEMBL6261925 0.78 PTPRC (1.00) PTPRCALDH1A1CTSLPTPN13MAPT
SCHEMBL20458935 0.77 MTNR1A (0.51) LMNACYP2C19MAPTMTNR1AMTNR1B
SCHEMBL26572450 0.77 KMT2A (0.56) SMN1; SMN2ALDH1A1LMNACYP2C19CYP3A4
SCHEMBL26567156 0.77 PTPRC (0.46) PTPRCSMN1; SMN2LMNACYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed